When a patient is diagnosed with non-muscle invasive bladder cancer (NMIBC), how do you tailor the conversation and treatment plan to their individual needs (and fears)? In part two of the 2025 NMIBC Creator Weekend™ series, host Dr. Vignesh Packiam is joined by Dr. Sima Porten from UCSF and Dr. Patrick Hensley from the University of Kentucky to discuss patient-centered diagnostic and therapeutic approaches for non-muscle invasive bladder cancer.
---
This podcast is supported by:
Ferring Pharmaceuticals
https://www.ferring.com/home-classic/people-and-families/uro-uro-oncology/bladder-cancer/
---
SYNPOSIS
The conversation covers initial patient consultations, discussing diagnoses, personalized treatment options such as BCG, gemcitabine, clinical trials, and managing side effects. The experts emphasize the importance of clear communication, understanding patient preferences, and tailoring approaches to enhance the patient's quality of life. They also explore insights from recent studies like the CISTO trial and highlight novel research directions.
---
TIMESTAMPS
00:00 - Introduction
04:28 - Counseling Patients on Diagnostic Findings
12:03 - Symptom Management and Patient Care
19:30 - Post-Procedure Care and Counseling
28:50 - Recovery After TURBT: Medications and Patient Care
44:16 - The Impact of Radical Cystectomy on Quality of Life
49:15 - Final Thoughts and Future Directions in Bladder Cancer Care
---
RESOURCES
NIMBUS Study
https://pubmed.ncbi.nlm.nih.gov/32446864/